Analystreport

Cascadian Therapeutics Inc (NASDAQ: CASC) was given a new $10.00 price target on by analysts at Cantor Fitzgerald. They now have a "hold" rating on the stock.

CASCADIAN THERAPEUTICS INC  (CASC) 
Last cascadian therapeutics inc earnings: 11/8 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.cascadianrx.com